These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 21220252)
41. The role of beta-blockers in the management of chronic obstructive pulmonary disease. Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360 [TBL] [Abstract][Full Text] [Related]
42. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. Le Jemtel TH; Padeletti M; Jelic S J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727 [TBL] [Abstract][Full Text] [Related]
46. Pulmonary effects of nebivolol. Dal Negro R Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367 [TBL] [Abstract][Full Text] [Related]
47. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Qaseem A; Snow V; Shekelle P; Sherif K; Wilt TJ; Weinberger S; Owens DK; Ann Intern Med; 2007 Nov; 147(9):633-8. PubMed ID: 17975186 [TBL] [Abstract][Full Text] [Related]
51. Other important applications for beta-blockers in high-risk patients. Egan BM; Chilton RJ Postgrad Med; 2003 Dec; 114(6 Suppl Role):35-48. PubMed ID: 19667668 [TBL] [Abstract][Full Text] [Related]
52. [Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment]. Rasmussen DB; Lange P; Jensen MT Ugeskr Laeger; 2015 Sep; 177(38):V02150184. PubMed ID: 26376419 [TBL] [Abstract][Full Text] [Related]
53. Use of beta-blockers in chronic congestive heart failure. Mahanonda N; Samranthin M; Panyarachun S J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491 [TBL] [Abstract][Full Text] [Related]
54. β-Blockers, heart disease and COPD: current controversies and uncertainties. Baker JG; Wilcox RG Thorax; 2017 Mar; 72(3):271-276. PubMed ID: 27927840 [TBL] [Abstract][Full Text] [Related]
55. Beta-blockers in COPD: time for reappraisal. Lipworth B; Wedzicha J; Devereux G; Vestbo J; Dransfield MT Eur Respir J; 2016 Sep; 48(3):880-8. PubMed ID: 27390282 [TBL] [Abstract][Full Text] [Related]
56. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis. Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016 [TBL] [Abstract][Full Text] [Related]
57. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD]. Glaab T; Weiss T Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165 [TBL] [Abstract][Full Text] [Related]
58. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly. Leitao Filho FS; Choi L; Sin DD Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878 [TBL] [Abstract][Full Text] [Related]
59. Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease. Wade C; Wells JM Expert Rev Respir Med; 2020 Jul; 14(7):671-678. PubMed ID: 32250198 [TBL] [Abstract][Full Text] [Related]
60. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations. Mersfelder TL; Shiltz DL Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]